USPTO grants patent to Vistagen’s neuropathic pain treatment
The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...
WCBD3d
2 Your Health: FDA approves non-opioid pain medication
Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...
FDA approves non-opioid pain medication dubbed possible medical ‘game changer’
The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.
WOOD Grand Rapids on MSN4d
New type of non-opioid pain medication approved by FDA
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
New non-opioid drug introduces new class of pain management medication
Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.
hometownstations4d
FDA approves new non-opioid pain medication
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...
US FDA approves suzetrigne: Why the non-opioid painkiller may be a game changer
Opioids are a class of drugs that “derive from, or mimic, natural substances found in the opium poppy plant”, according to ...
Woman's World on MSN6d
FDA Approves New Non-Opioid Painkiller for Acute Pain-What to Know!
A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...
verywellhealth6d
New FDA-Approved Painkiller Is a Safer Alternative to Opioids
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
Healio6d
FDA approves nonopioid Journavx for moderate to severe acute pain
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
BioPharma Dive6d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...